
Conference Coverage
23 days ago
Elevate-Derm Summer Clinical Pearlsabout 1 month ago
Whole-Patient Care in Pediatric Dermatology: Lessons From SPD 2026about 1 month ago
Securing GLP-1 Access and Exploring Hidradenitis Suppurativa TrialsLatest News

Beyond the Skin: How Inflammation Connects Dermatologic Disease

DermNexus 2026 Day 1 Recap: Emerging Therapies and Clinical Insights

Q&A: Where Skin Cancer Prevention Falls Short, With Leigh Ann Pansch, NP

Gene Expression Profiling and Adjuvant Radiation Decisions in CSCC

DermNexus 2026 to Explore Innovations in Inflammatory Skin Disease
Videos

Shorts










Dermatology Times Digital Edition









Continuing Medical Education
All News

Guselkumab improved axial symptoms and MRI-assessed sacroiliac joint inflammation vs placebo in axial psoriatic arthritis in the phase 4 STAR trial.

Experts explore individualized plaque psoriasis treatment, highlighting biologic selection, adherence, comorbidities, and patient-centered care.

A pediatric dermatologist explains how to read itch, sleep, and quality-of-life findings from phase 2 nemolizumab data in children aged 2 - 11.

Palvella unveiled QTORIN docetaxel, a topical candidate for extramammary Paget’s disease, with FDA talks planned in early 2027 ahead of a phase 2 study.

For Healthy Skin Month, a dermatologist discusses winter sun protection, overlooked patients in skin cancer screening, bemotrizinol, and AI in detection.

Clinicians at a Dermatology Times Case-Based Roundtable, moderated by Jessica Mercer, MD, debated severity scoring, trial data, and monitoring when selecting JAK inhibitors for alopecia areata.

For Healthy Skin Month, a dermatology nurse practitioner shares why sunscreen matters in winter and how clinicians can close gaps in skin cancer screening.

Learn why indoor tanning remains a preventable source of melanoma, what research suggests about why some patients experience difficulty stopping, and how a clinical pilot called TanPrevent could connect education with follow-up support to help them quit and stay quit.

Bioelements and Celluma partnered to educate estheticians on integrating LED light therapy into customized facial treatments for acne and aging skin.

FDA implements updated iPLEDGE REMS requirements for isotretinoin, allowing at-home pregnancy testing and reducing prescription and counseling burdens.

Bosakitug failed to meet primary and secondary endpoints in a phase 2 atopic dermatitis trial despite evidence of TSLP target engagement.

Recent dermatology research explores chronic hand eczema prevalence, cancer risk in morphea, pernio, biologic optimization in HS, and melanoma risk prediction.

Hypochlorous acid sprays are trending as a post-gym skin care essential, but can they actually prevent sweat-related breakouts?

Clinicians discuss how type 2 inflammation informs treatment decisions across AD, prurigo nodularis, CSU, and bullous pemphigoid.

A pediatric dermatologist explains how CALM count, size, age, and associated findings separate benign spots from neurofibromatosis type 1 and its mimics.

























